SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lisa-Ann Fraser, Jorge G. Burneo, J. Alexander Fraser, Enzyme-inducing antiepileptic drugs and fractures in people with epilepsy: A systematic review, Epilepsy Research, 2015, 116, 59

    CrossRef

  2. 2
    Marianna Fedorenko, Mary L. Wagner, Brenda Y. Wu, Survey of risk factors for osteoporosis and osteoprotective behaviors among patients with epilepsy, Epilepsy & Behavior, 2015, 45, 217

    CrossRef

  3. 3
    Hepsen Mine Serin, Zehra Pınar Koç, Berfin Temelli, İhsan Esen, The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine, Epilepsy & Behavior, 2015, 51, 221

    CrossRef

  4. 4
    G. Krämer, Antiepileptika-Osteopathie oder Schmid-Kruse-Syndrom, Zeitschrift für Epileptologie, 2014, 27, 3, 209

    CrossRef

  5. 5
    Chunhong Shen, Feng Chen, Yinxi Zhang, Yi Guo, Meiping Ding, Association between use of antiepileptic drugs and fracture risk: A systematic review and meta-analysis, Bone, 2014, 64, 246

    CrossRef

  6. 6
    Arne Reimers, New antiepileptic drugs and women, Seizure, 2014, 23, 8, 585

    CrossRef

  7. 7
    Md. Jamir Anwar, K.V. Radhakrishna, Divya Vohora, Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice, Canadian Journal of Physiology and Pharmacology, 2014, 92, 6, 507

    CrossRef

  8. 8
    Jules Beal, A worldwide yearly survey of new data in adverse drug reactions, 2014,

    CrossRef

  9. 9
    Steve S. Chung, Courtney Schusse, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2014,

    CrossRef

  10. 10
    Sona Fekete, Julius Simko, Iveta Gradosova, Jana Malakova, Helena Zivna, Vladimir Palicka, Pavel Zivny, The effect of levetiracetam on rat bone mass, structure and metabolism, Epilepsy Research, 2013, 107, 1-2, 56

    CrossRef